Advertisement
New Zealand markets close in 4 hours 19 minutes
  • NZX 50

    11,722.50
    -21.89 (-0.19%)
     
  • NZD/USD

    0.6107
    +0.0020 (+0.32%)
     
  • NZD/EUR

    0.5628
    -0.0002 (-0.03%)
     
  • ALL ORDS

    8,009.50
    +2.40 (+0.03%)
     
  • ASX 200

    7,744.30
    -1.30 (-0.02%)
     
  • OIL

    79.96
    -0.01 (-0.01%)
     
  • GOLD

    2,094.60
    -1.10 (-0.05%)
     
  • NASDAQ

    18,302.91
    +259.11 (+1.44%)
     
  • FTSE

    7,682.50
    +52.48 (+0.69%)
     
  • Dow Jones

    39,087.38
    +90.98 (+0.23%)
     
  • DAX

    17,735.07
    +56.87 (+0.32%)
     
  • Hang Seng

    16,589.44
    +78.04 (+0.47%)
     
  • NIKKEI 225

    39,910.82
    +744.62 (+1.90%)
     
  • NZD/JPY

    91.6310
    +0.3710 (+0.41%)
     

Lotte Chemical Titan Holding Berhad Full Year 2022 Earnings: RM0.31 loss per share (vs RM0.46 profit in FY 2021)

Lotte Chemical Titan Holding Berhad (KLSE:LCTITAN) Full Year 2022 Results

Key Financial Results

  • Revenue: RM10.0b (up 1.9% from FY 2021).

  • Net loss: RM714.6m (down by 169% from RM1.04b profit in FY 2021).

  • RM0.31 loss per share (down from RM0.46 profit in FY 2021).

earnings-and-revenue-growth
earnings-and-revenue-growth

All figures shown in the chart above are for the trailing 12 month (TTM) period

Lotte Chemical Titan Holding Berhad Earnings Insights

Looking ahead, revenue is expected to decline by 4.6% p.a. on average during the next 3 years, while revenues in the Chemicals industry in Malaysia are expected to grow by 6.1%.

Performance of the Malaysian Chemicals industry.

The company's shares are down 1.3% from a week ago.

Risk Analysis

You still need to take note of risks, for example - Lotte Chemical Titan Holding Berhad has 1 warning sign we think you should be aware of.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Join A Paid User Research Session
You’ll receive a US$30 Amazon Gift card for 1 hour of your time while helping us build better investing tools for the individual investors like yourself. Sign up here